iGb3 Antibodies

Santa Cruz Biotechnology offers a broad range of iGb3 monoclonal antibodies for the detection and analysis of the iGb3 glycosphingolipid. Multiple research applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). iGb3 plays a central role in immune response and cell signaling, serving as a ligand for specific receptors involved in T cell activation and differentiation. Understanding iGb3 and its interactions is crucial for investigating various diseases, including autoimmune disorders and cancer. Researchers can explore the molecular mechanisms of iGb3 in cellular processes through detailed characterization studies. Advanced imaging techniques and biochemical assays enable the visualization and quantification of iGb3 expression patterns across different tissue types. Investigating iGb3's role in signaling cascades provides valuable insights into immune system regulation and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies for iGb3 support researchers worldwide in advancing scientific understanding of immune system function and disease mechanisms.